In vitro efficacy of a novel chemoradiopotentiator - taxoltere metro

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 1, 2000, Pages 159-163

  Yang, Li Xi ^a   Wang, Hui Juan ^a   Holton, Robert A ^b  

^a Intgd Radiat Oncol Grad Med E   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Chemotherapy; Paclitaxel; Paclitaxel analogs; Radiopotentiation; Radiotherapy

Indexed keywords

DOCETAXEL; PACLITAXEL; RADIOSENSITIZING AGENT;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL SURVIVAL; CHO CELL; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; HUMAN; HUMAN CELL; HYPOXIC CELL; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL HYPOXIA; CELL SURVIVAL; CHO CELLS; COLONIC NEOPLASMS; CRICETINAE; DRUG RESISTANCE, NEOPLASM; HUMANS; PACLITAXEL; RADIATION-SENSITIZING AGENTS; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0033970945     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00356-9     Document Type: Article

References (24)

1. Rowinsky E.K., Donehower R.C. Paclitaxel (Taxol). New Engl J Med. 332:1995;1004-1008.
2. Horwitz S.B. Mechanism of action of taxol. TIPS. 13:1992;134-136.
3. Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA. 77:1980;1561-1565.
4. Sinclair W.K. Cyclic X-ray response in mammalian cells in vitro. Radiat Res. 33:1968;620-643.
5. Choy H., Rodriguez F.F., Koester S., et al. Investigation of taxol as a potential radiation sensitizer. Cancer. 71:1993;3774-3778.
6. Gapta N., Hu L., Fan P.D., et al. Effect of taxol and radiation on brain tumor cell lines. Proc Am Assoc Cancer Res. 35:1994;647.
7. Geard C.R., Jones J.M., Schiff P.B. Taxol and radiation. J Natl Cancer Inst Monogr. 15:1993;89-94.
8. Lokeshwas B.L., Ferrell S.M., Block N.L. Enhancement of radiation response of prostatic carcinoma by taxol Therapeutic potential for late-stage malignancy . Anticancer Res. 15:1995;93-98.
9. Milas L., Hunter N.R., Mason K.A., et al. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res. 54:1994;3506-3510.
10. Tishler R.B., Geard C.R., Hall E.J., et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52:1992;3495-3497.
11. Ingram M.J., Redpath J.L. Subadditive interaction of radiation and taxol in vitro. Int J Radiat Oncol Biol Phys. 37:1997;1139-1144.
12. Liebmann J., Herscher L., Fisher J., et al. Antagonism of paclitaxel toxicity by X-rays Implications for combined modality therapy . Int J Oncol. 8:1996;991-996.
13. Talwar N., Redpath J.L. Schedule dependence of the interaction of radiation and taxol in HeLa cells. Radiat Res. 148:1997;48-53.
14. Hennequin C., Giocanti N., Favaudon N. Interaction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells. Cancer Res. 56:1996;1842-1850.
15. Leonard C.E., Chan D.C., Chou T.-C., et al. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res. 56:1996;5198-5204.
16. Liebmann J., Cook J.A., Fisher J., et al. In vitro studies of taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst. 86:1994;441-446.
17. Hall E.J. Radiosensitizers and bioreductive drugs. Hall E.J. Radiobiology for the radiologist. 4th ed. 1994;165-181 Lippincott-Raven, Philadelphia, PA.
18. Bissery M-C, Guenard D, Gueritte-Voegelein F; et al. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 1991;51:4845-4852.
19. Breuniger L.M., Paul S., Gaughan K., et al. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 55:1995;5342-5347.
20. Dumontet C., Duran G.E., Steger K.A., et al. Resistance mechanisms in human sarcoma mutants derived by single step exposure to paclitaxel (taxol). Cancer Res. 56:1996;1091-1097.
21. Cabral R.F., Brady R.C., Schibler M.J. A mechanism of cellular resistance to drugs that interfere with microtubule assembly. Ann NY Acad Sci. 466:1986;745-751.
22. Greenberger L.M., Williams S.S., Horwitz B.S. Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins. J Biol Chem. 262:1987;1685-1692.
23. Roy SN, Horwitz SB. A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res 1985;45:3856-3862.
24. Schibler MJ, Cabral F. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin. J Cell Biol 1986;102:1522-1528.